Total number of projects: 7
As coordinator: 0
As participant: 7
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2013 | 0 | 2.496.221 | 2.496.221 | 1 | ||
2011 | 0 | 13.838.297 | 2.117.728 | 4 | ||
2010 | 0 | 22.495.023 | 377.217 | 2 |
Total number of partners: 138
Partner loyalty:
Frequent Partner: (> 2 projects): 23
Rare Partner: 115
Frequent / Rare Partner Ratio: 0.2
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2013-05-01 | Targeting RAS oncogene addiction | RASTARGET | participant | 2.496.221 | 1 |
2011-02-01 | Targeting the tumour microenvironment to improve pancreatic cancer prognosis | EPC-TM-Net | participant | 3.000.000 | 17 |
2011-01-01 | New approaches for the targeted therapy of Non-Small Cell Lung Cancer | LUNGTARGET | participant | 2.997.332 | 10 |
2011-01-01 | ERA-NET on Translational Cancer Research | TRANSCAN | participant | 1.999.956 | 29 |
2011-01-01 | Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics | PREDICT | participant | 5.841.009 | 14 |
2010-10-01 | Epigenetics towards systems biology | EPIGENESYS | participant | 11.995.024 | 28 |
2010-07-01 | Breast Cancer Somatic Genetics Study | BASIS | participant | 10.499.999 | 15 |